RecruitingNot ApplicableNCT07701135

Antimicrobial Stewardship Effects of Interpretive Comments for Faecal PCR Tests


Sponsor

Medical Research Institute of New Zealand

Enrollment

10,000 participants

Start Date

Jun 2, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

Bacterial gastroenteritis is a common condition seen in Aotearoa New Zealand, which is typically diagnosed by PCR testing on a stool sample. Most causes of bacterial gastroenteritis (e.g. Campylobacter spp, Salmonella spp, Yersinia spp) cause a self-limiting illness and antibiotic therapy is not required. Indeed, guidelines available for community healthcare providers in Aotearoa (e.g. Community HealthPathways, recently released national antimicrobial guidelines Te Whata Kura) recommend against antibiotic therapy for the vast majority of cases. A recent internal analysis at Awanui Laboratories of community faecal pathogen PCR testing revealed that antibiotic prescribing was very common after a positive result (ranging between 20-40% for the various individual pathogens), which suggests many community healthcare providers may not be following the recommended approach for the management of these infections. Given how common infectious gastroenteritis is in Aotearoa, and the volume of tests performed (approximately 100,000 through the Awanui network per year), this prescribing behaviour may represent a large volume of unnecessary antibiotic use in our communities, with resultant potential harmful effects at the individual patient level and population level via side effects, disruption to the faecal microbiome, and impacts on antimicrobial resistance (AMR). In previous work we have demonstrated that interpretive comments, when added to laboratory reports, can have a significant positive effect on prescriber behaviour (https://doi.org/10.1093/jac/dkad384), but this has not been examined in relation to faecal pathogen testing.


Eligibility

Min Age: 6 Months

Inclusion Criteria3

  • Age over six months
  • Stool sample submitted to Awanui Labs for faecal bacterial pathogen testing from a community health provider during the study period
  • Test results report the detection of: Campylobacter spp, Shigella spp/Entero-invasive Escherichia coli, Salmonella spp, Yersinia spp, or Aeromonas spp.

Exclusion Criteria2

  • Samples where only Clostridioides difficile or Helicobacter pylori testing has been requested will be excluded
  • Samples sent for Public Health testing (e.g. testing for clearance of Salmonella spp) will be excluded.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERInterpretive comment on laboratory report

Interpretive commend added to laboratory report - contents of comment will depend on associated arm


Locations(4)

Awanui Labs Auckland

Auckland, New Zealand

Awanui Labs Christchurch

Christchurch, New Zealand

Awanui Labs Dunedin

Dunedin, New Zealand

Awanui Labs Wellington

Wellington, New Zealand

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07701135


Related Trials